Interestingly, high levels of B-cell-activating factor (BAFF), an important mediator of B-cell survival and therapeutic target in SLE patients, were found to increase glucose metabolism and glycolysis via mTORC1 activation and promotion of protein synthesis [59, 60]. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.